For: | Wang HJ, Zhu JS, Zhang Q, Sun Q, Guo H. High level of ezrin expression in colorectal cancer tissues is closely related to tumor malignancy. World J Gastroenterol 2009; 15(16): 2016-2019 [PMID: 19399936 DOI: 10.3748/wjg.15.2016] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v15/i16/2016.htm |
Number | Citing Articles |
1 |
Yu Mi Jeon, Bu Soon Son, Mi Young Lee. Proteomic identification of the differentially expressed proteins in human lung epithelial cells by airborne particulate matter. Journal of Applied Toxicology 2011; 31(1): 45 doi: 10.1002/jat.1566
|
2 |
Fredrik Jörgren, Mef Nilbert, Eva Rambech, Pär-Ola Bendahl, Gudrun Lindmark. Ezrin expression in rectal cancer predicts time to development of local recurrence. International Journal of Colorectal Disease 2012; 27(7): 893 doi: 10.1007/s00384-011-1397-z
|
3 |
Susan Fanayan, Joshua T. Smith, Ling Y. Lee, Fangfei Yan, Michael Snyder, William S. Hancock, Edouard Nice. Proteogenomic Analysis of Human Colon Carcinoma Cell Lines LIM1215, LIM1899, and LIM2405. Journal of Proteome Research 2013; 12(4): 1732 doi: 10.1021/pr3010869
|
4 |
Komal Qureshi-Baig, Diana Kuhn, Elodie Viry, Vitaly I. Pozdeev, Martine Schmitz, Fabien Rodriguez, Pit Ullmann, Eric Koncina, Martin Nurmik, Sonia Frasquilho, Petr V. Nazarov, Nikolaus Zuegel, Marc Boulmont, Yervand Karapetyan, Laurent Antunes, Daniel Val, Michel Mittelbronn, Bassam Janji, Serge Haan, Elisabeth Letellier. Hypoxia-induced autophagy drives colorectal cancer initiation and progression by activating the PRKC/PKC-EZR (ezrin) pathway. Autophagy 2020; 16(8): 1436 doi: 10.1080/15548627.2019.1687213
|
5 |
Qunyan Jin, Guangming Liu, Phillip P. Domeier, Wei Ding, Kathleen M. Mulder, Olivier de Wever. Decreased Tumor Progression and Invasion by a Novel Anti-Cell Motility Target for Human Colorectal Carcinoma Cells. PLoS ONE 2013; 8(6): e66439 doi: 10.1371/journal.pone.0066439
|
6 |
Asmaa Gaber Abdou, Saber Sakr, Moshira Mohammed Abd Elwahed, Eman Kamal Eladly. Immunohistochemical assessment of ezrin and moesin in colorectal carcinoma. Ultrastructural Pathology 2016; 40(4): 181 doi: 10.3109/01913123.2016.1155683
|
7 |
Lakshmi Mohan Lathika, Jagathnath Krishna Kumarapillai Moh Nair, Valliamma Neelakandapilla Saritha, Kunjuraman Sujathan, Sreeharshan Sreeja. Role of phospho–ezrin in differentiating thyroid carcinoma. Scientific Reports 2019; 9(1) doi: 10.1038/s41598-019-42612-0
|
8 |
Arielis Rodríguez-Ulloa, Yassel Ramos, Jeovanis Gil, Yasser Perera, Lila Castellanos-Serra, Yairet García, Lázaro Betancourt, Vladimir Besada, Luis J. González, Jorge Fernández-de-Cossio, Aniel Sanchez, Joem M. Serrano, Hernán Farina, Daniel F. Alonso, Boris E. Acevedo, Gabriel Padrón, Alexis Musacchio, Silvio E. Perea. Proteomic Profile Regulated by the Anticancer Peptide CIGB-300 in Non-Small Cell Lung Cancer (NSCLC) Cells. Journal of Proteome Research 2010; 9(10): 5473 doi: 10.1021/pr100728v
|
9 |
Nancy Gavert, Amir Ben-Shmuel, Vance Lemmon, Thomas Brabletz, Avri Ben-Ze'ev. Nuclear factor-κB signaling and ezrin are essential for L1-mediated metastasis of colon cancer cells. Journal of Cell Science 2010; 123(12): 2135 doi: 10.1242/jcs.069542
|
10 |
Feng Liang, Yangxin Wang, Ligen Shi, Jianmin Zhang. Association of Ezrin expression with the progression and prognosis of gastrointestinal cancer: a meta-analysis. Oncotarget 2017; 8(54): 93186 doi: 10.18632/oncotarget.21473
|
11 |
Prabhu Arumugam, Stefano Partelli, Stacey J. Coleman, Ivana Cataldo, Stefania Beghelli, Claudio Bassi, Nilukushi Wijesuriya, Jo-Anne Chin Aleong, Fieke E.M. Froeling, Aldo Scarpa, Hemant M. Kocher. Ezrin Expression Is an Independent Prognostic Factor in Gastro-intestinal Cancers. Journal of Gastrointestinal Surgery 2013; 17(12): 2082 doi: 10.1007/s11605-013-2384-1
|
12 |
Manveen K. Sethi, Morten Thaysen-Andersen, Hoguen Kim, Cheol Keun Park, Mark S. Baker, Nicolle H. Packer, Young-Ki Paik, William S. Hancock, Susan Fanayan. Quantitative proteomic analysis of paired colorectal cancer and non-tumorigenic tissues reveals signature proteins and perturbed pathways involved in CRC progression and metastasis. Journal of Proteomics 2015; 126: 54 doi: 10.1016/j.jprot.2015.05.037
|
13 |
Lin Lin-juan, Zhang Jin-hui, Wang Yan, Jin Zheng, Cai Ying-lan. Clinical significance of Ezrin expression in ultrasound-guided HCC biopsy. Proceedings 2011 International Conference on Human Health and Biomedical Engineering 2011; : 1133 doi: 10.1109/HHBE.2011.6029025
|
14 |
Krishnendu Khan, Briana Long, Gauravi M. Deshpande, Paul L. Fox. Bidirectional Tumor-Promoting Activities of Macrophage Ezrin. International Journal of Molecular Sciences 2020; 21(20): 7716 doi: 10.3390/ijms21207716
|
15 |
Premila D. Leiphrakpam, Ashwani Rajput, Michelle Mathiesen, Ekta Agarwal, Audrey J. Lazenby, Chandrakanth Are, Michael G. Brattain, Sanjib Chowdhury. Ezrin expression and cell survival regulation in colorectal cancer. Cellular Signalling 2014; 26(5): 868 doi: 10.1016/j.cellsig.2014.01.014
|
16 |
Marcelo Patara, Erika Maria Monteiro Santos, Renata de Almeida Coudry, Fernando Augusto Soares, Fábio Oliveira Ferreira, Benedito Mauro Rossi. Ezrin Expression as a Prognostic Marker in Colorectal Adenocarcinoma. Pathology & Oncology Research 2011; 17(4): 827 doi: 10.1007/s12253-011-9389-4
|
17 |
Koichiro Mori, Yuji Toiyama, Kohei Otake, Shozo Ide, Hiroki Imaoka, Masato Okigami, Yoshinaga Okugawa, Hiroyuki Fujikawa, Susumu Saigusa, Junichiro Hiro, Minako Kobayashi, Masaki Ohi, Koji Tanaka, Yasuhiro Inoue, Yuhko Kobayashi, Yasuhiko Mohri, Issei Kobayashi, Ajay Goel, Masato Kusunoki. Successful identification of a predictive biomarker for lymph node metastasis in colorectal cancer using a proteomic approach. Oncotarget 2017; 8(63): 106935 doi: 10.18632/oncotarget.22149
|
18 |
Asmaa Gaber Abdou, Alaa Hassan Maraee, Eman Mostafa Mohamed El-Sayed, Nada Farag Elnaidany. Immunohistochemical expression of ezrin in cutaneous basal and squamous cell carcinomas. Annals of Diagnostic Pathology 2011; doi: 10.1016/j.anndiagpath.2011.05.005
|
19 |
Iris Car, Antje Dittmann, Olga Vasieva, Luka Bočkor, Petra Grbčić, Nikolina Piteša, Marko Klobučar, Sandra Kraljević Pavelić, Mirela Sedić. Ezrin Inhibition Overcomes Acquired Resistance to Vemurafenib in BRAFV600E-Mutated Colon Cancer and Melanoma Cells In Vitro. International Journal of Molecular Sciences 2023; 24(16): 12906 doi: 10.3390/ijms241612906
|
20 |
Premila D. Leiphrakpam, Michael G. Brattain, Jennifer D. Black, Jing Wang. TGFβ and IGF1R signaling activates protein kinase A through differential regulation of ezrin phosphorylation in colon cancer cells. Journal of Biological Chemistry 2018; 293(21): 8242 doi: 10.1074/jbc.RA117.001299
|
21 |
Rongju Zhang, Shaohui Zhang, Rongge Xing, Qin Zhang. High expression of EZR (ezrin) gene is correlated with the poor overall survival of breast cancer patients. Thoracic Cancer 2019; 10(10): 1953 doi: 10.1111/1759-7714.13174
|
22 |
Ganesh Kumar Barik, Osheen Sahay, Debasish Paul, Manas Kumar Santra. Ezrin gone rogue in cancer progression and metastasis: An enticing therapeutic target. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2022; 1877(4): 188753 doi: 10.1016/j.bbcan.2022.188753
|
23 |
Zhe Wang, Mao-Lin He, Jin-Min Zhao, Hai-Hui Qing, Yang Wu. Meta-analysis of Associations of the Ezrin Gene with Human Osteosarcoma Response to Chemotherapy and Prognosis. Asian Pacific Journal of Cancer Prevention 2013; 14(5): 2753 doi: 10.7314/APJCP.2013.14.5.2753
|
24 |
Beibei Zhou, Jun Leng, Meng Hu, Li Zhang, Zhan Wang, Dongying Liu, Xiaoling Tong, Beibei Yu, Yi Hu, Chaohua Deng, Yanping Liu, Qiuping Zhang. Ezrin is a key molecule in the metastasis of MOLT4 cells induced by CCL25/CCR9. Leukemia Research 2010; 34(6): 769 doi: 10.1016/j.leukres.2009.11.025
|
25 |
Afrodite Athanasopoulou, Panagiotis Aroukatos, Dimitrios Nakas, Maria Repanti, Helen Papadaki, Vasiliki Bravou. Decreased ezrin and paxillin expression in human urothelial bladder tumors correlate with tumor progression. Urologic Oncology: Seminars and Original Investigations 2013; 31(6): 836 doi: 10.1016/j.urolonc.2011.07.003
|
26 |
Manveen K Sethi, Hoguen Kim, Cheol Keun Park, Mark S Baker, Young-Ki Paik, Nicolle H Packer, William S Hancock, Susan Fanayan, Morten Thaysen-Andersen. In-depthN-glycome profiling of paired colorectal cancer and non-tumorigenic tissues reveals cancer-, stage- and EGFR-specific protein N-glycosylation. Glycobiology 2015; 25(10): 1064 doi: 10.1093/glycob/cwv042
|
27 |
Jean Carlos Lipreri da Silva, Hugo Passos Vicari, João Agostinho Machado-Neto. Perspectives for Targeting Ezrin in Cancer Development and Progression. Future Pharmacology 2023; 3(1): 61 doi: 10.3390/futurepharmacol3010005
|
28 |
Daphne Gschwantler-Kaulich, Camilla Natter, Stefan Steurer, Ingrid Walter, Almut Thomas, Mohamed Salama, Christian F. Singer. Increase in ezrin expression from benign to malignant breast tumours. Cellular Oncology 2013; 36(6): 485 doi: 10.1007/s13402-013-0153-5
|
29 |
Pelin Balcik-Ercin, Laure Cayrefourcq, Rama Soundararajan, Sendurai A. Mani, Catherine Alix-Panabières. Epithelial-to-Mesenchymal Plasticity in Circulating Tumor Cell Lines Sequentially Derived from a Patient with Colorectal Cancer. Cancers 2021; 13(21): 5408 doi: 10.3390/cancers13215408
|